Epix Electrosurgical Probes with Smoke Evacuation, Angled L-Hook Tip, 5mm x 42 cm REF CW002 QTY...

FDA Device Recall #Z-0509-2020 — Class II — December 12, 2018

Recall Summary

Recall Number Z-0509-2020
Classification Class II — Moderate risk
Date Initiated December 12, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Applied Medical Resources Corp
Location Rancho Santa Margarita, CA
Product Type Devices
Quantity 28 units Domestically - 112 units Internationally

Product Description

Epix Electrosurgical Probes with Smoke Evacuation, Angled L-Hook Tip, 5mm x 42 cm REF CW002 QTY: 1 - Product Usage: The Epix Electrosurgical Probe with Smoke Evacuation is intended to deliver energy from an independent monopolar electrosurgical generator to cut and coagulate tissue during laparoscopic surgical procedures where the device is introduced into the body through a cannula. The device may be used for the evacuation of smoke created by electrosurgery at the surgical site.

Reason for Recall

Unintentional shifting of the tip insulation of the firm's electrosurgical probes.

Distribution Pattern

Worldwide distribution - US Nationwide distribution and countries of Belgium; Germany; Switzerland; Spain; Finland; France; Great Britain; Israel; India; Italy; Lebanon; Netherlands; and Portugal.

Lot / Code Information

Model Number: CW002 Lot Numbers: 1336418 and 1340803 Model # Lot # UDI Code CW002 1336418 (01)00607915136147(17)210912(30)01(10)1336418 CW002 1340206 (01)00607915136147(17)211029(30)01(10)1340206 TA211 1340118 (01)20607915139050(17)210812(30)01(10)1340118 TA211 1342169 (01)20607915139050(17)210812(30)01(10)1342169

Other Recalls from Applied Medical Resources Corp

Recall # Classification Product Date
Z-1010-2026 Class II Kii Low Profile, Bladed Dual Pack , Qty. 1 5x55... Dec 11, 2025
Z-1388-2024 Class II Epix Universal Clip Applier, REF: CA500, STERILEEO Jan 30, 2024
Z-1389-2024 Class II Epix Universal Clip Applier, REF: CA500, STERIL... Jan 30, 2024
Z-2160-2020 Class II DR. THAMES - LAP CHOLE, REF: K0880, UDI: (01)3... Mar 17, 2020
Z-2161-2020 Class II Clip Applier Kit, REF: K2887, UDI: (01)30607915... Mar 17, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.